| Year |
Citation |
Score |
| 2024 |
Kamal A, Boerner J, Assad H, Chen W, Simon MS. The Effect of Statins on Markers of Breast Cancer Proliferation and Apoptosis in Women with In Situ or Early-Stage Invasive Breast Cancer. International Journal of Molecular Sciences. 25. PMID 39273534 DOI: 10.3390/ijms25179587 |
0.41 |
|
| 2024 |
Patil V, Ruterbusch JJ, Chen W, Boerner JL, Abdulfatah E, Alosh B, Pardeshi V, Shaik AN, Bandyopadhyay S, Ali-Fehmi R, Cote ML. Multiplicity of benign breast disease lesions and breast cancer risk in African American women. Frontiers in Oncology. 14: 1410819. PMID 38817898 DOI: 10.3389/fonc.2024.1410819 |
0.36 |
|
| 2021 |
Brock EJ, Jackson RM, Boerner JL, Li Q, Tennis MA, Sloane BF, Mattingly RR. Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma. Plos One. 16: e0252314. PMID 34048471 DOI: 10.1371/journal.pone.0252314 |
0.355 |
|
| 2020 |
Shaik AN, Kiavash K, Stark K, Boerner JL, Ruterbusch JJ, Deirawan H, Bandyopadhyay S, Ali-Fehmi R, Dyson G, Cote ML. Inflammation markers on benign breast biopsy are associated with risk of invasive breast cancer in African American women. Breast Cancer Research and Treatment. PMID 33113091 DOI: 10.1007/s10549-020-05983-x |
0.346 |
|
| 2020 |
Bao B, Teslow EA, Mitrea C, Boerner JL, Dyson G, Bollig-Fischer A. Role of TET1 and 5hmC in an obesity-linked pathway driving cancer stem cells in triple-negative breast cancer. Molecular Cancer Research : McR. PMID 32913111 DOI: 10.1158/1541-7786.Mcr-20-0359 |
0.505 |
|
| 2020 |
Purrington KS, Raychaudhuri S, Simon MS, Clark J, Ratliff V, Dyson G, Craig DB, Boerner JL, Beebe-Dimmer JL, Schwartz AG. Heritable susceptibility to breast cancer among African American women in the Detroit Research on Cancer Survivors Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32868316 DOI: 10.1158/1055-9965.Epi-20-0564 |
0.486 |
|
| 2020 |
Purrington KS, Knight J, Dyson G, Ali-Fehmi R, Schwartz AG, Boerner JL, Bandyopadhyay S. CLCA2 expression is associated with survival among African American women with triple negative breast cancer. Plos One. 15: e0231712. PMID 32298355 DOI: 10.1371/Journal.Pone.0231712 |
0.493 |
|
| 2020 |
McKnight BN, Kim S, Boerner JL, Viola NT. Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer. Breast Cancer Research : Bcr. 22: 37. PMID 32295603 DOI: 10.1186/S13058-020-01270-1 |
0.528 |
|
| 2019 |
Purrington K, Dyson G, Craig D, Boerner J, Madden J, Beebe-Dimmer J, Schwartz AG, Simon M. Abstract 4175: Spectrum of heritable mutations in 43 known and candidate breast cancer susceptibility genes in African American women with breast cancer Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-4175 |
0.486 |
|
| 2018 |
Vaishampayan U, Podgorski I, Heilbrun LK, Lawhorn-Crews JM, Dobson KC, Boerner JL, Stark K, Smith D, Heath EI, Fontana J, Shields AF. Biomarkers and Bone Imaging Dynamics associated with Clinical outcomes of Oral Cabozantinib Therapy in Metastatic Castrate Resistant Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30327304 DOI: 10.1158/1078-0432.Ccr-18-1473 |
0.36 |
|
| 2018 |
Shah S, Brock EJ, Jackson RM, Ji K, Boerner JL, Sloane BF, Mattingly RR. Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation. Neoplasia (New York, N.Y.). 20: 951-963. PMID 30144784 DOI: 10.1016/J.Neo.2018.07.002 |
0.486 |
|
| 2018 |
Gadgeel SM, Pennell NA, Fidler MJ, Halmos B, Bonomi P, Stevenson J, Schneider B, Sukari A, Ventimiglia J, Chen W, Galasso C, Wozniak A, Boerner J, Kalemkerian GP. Phase II study of maintenance pembrolizumab in patients with extensive-stage small cell lung cancer (SCLC). Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29775808 DOI: 10.1016/J.Jtho.2018.05.002 |
0.356 |
|
| 2018 |
Colacino JA, Azizi E, Brooks MD, Harouaka R, Fouladdel S, McDermott SP, Lee M, Hill D, Madden J, Boerner J, Cote ML, Sartor MA, Rozek LS, Wicha MS. Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling. Stem Cell Reports. PMID 29606612 DOI: 10.1016/J.Stemcr.2018.03.001 |
0.442 |
|
| 2018 |
Thakur MK, Heilbrun L, Dobson K, Boerner J, Stark K, Li J, Smith D, Heath E, Fontana J, Vaishampayan U. Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer. Clinical Genitourinary Cancer. PMID 29534939 DOI: 10.1016/J.Clgc.2018.01.019 |
0.343 |
|
| 2018 |
Brock EJ, Jackson R, Boerner JL, Li Q, Sloane BF, Mattingly RR. Abstract B14: Sprouty4 regulates the transition to invasive breast ductal carcinoma through ERK/MAPK signaling Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-B14 |
0.519 |
|
| 2018 |
Shaik AN, Boerner JL, Cote ML, Dyson G, Ali-Fehmi R, Bandyopadhyay S, Purrington KS. Abstract B01: Immune cell infiltrates differ by obesity in tumor and adjacent normal breast tissue in African American women with triple-negative breast cancer Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-B01 |
0.386 |
|
| 2018 |
Shaik AN, Kiavash K, Stark K, Boerner JL, Ruterbusch JJ, Ali-Fehmi R, Cote ML. Abstract LB-337: Adipose inflammation and the risk of benign and malignant breast disease in African American women Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-337 |
0.435 |
|
| 2017 |
Bao B, Mitrea C, Wijesinghe P, Marchetti L, Girsch E, Farr RL, Boerner JL, Mohammad R, Dyson G, Terlecky SR, Bollig-Fischer A. Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity. Scientific Reports. 7: 44125. PMID 28281569 DOI: 10.1038/Srep44125 |
0.573 |
|
| 2017 |
Gadgeel SM, Ventimiglia J, Kalemkerian GP, Fidler MJ, Chen W, Sukari A, Halmos B, Boerner J, Wozniak AJ, Galasso C, Pennell NA. Phase II study of maintenance pembrolizumab (pembro) in extensive stage small cell lung cancer (ES-SCLC) patients (pts). Journal of Clinical Oncology. 35: 8504-8504. DOI: 10.1200/Jco.2017.35.15_Suppl.8504 |
0.318 |
|
| 2017 |
Wizner C, Ruterbusch J, Kubinec N, Dyson G, Levin A, Boerner J, Bock C. Abstract B33: Determination of protein expression of candidate prostate cancer genes from a novel region on chromosome 7 identified in African American men Cancer Epidemiology, Biomarkers & Prevention. 26. DOI: 10.1158/1538-7755.Disp16-B33 |
0.342 |
|
| 2017 |
Ruterbusch JJ, Cote ML, Boerner J, Abdulfatah E, Alosh B, Pardeshi V, Daaboul MF, Roquiz W, Ali-Fehmi R, Bandyopadhyay S. Abstract A15: Breast cancer subtype subsequent to a benign breast biopsy among African American women Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-A15 |
0.521 |
|
| 2017 |
Girsch EA, Bao B, Mitrea C, Dyson G, Boerner J, Polin L, Terlecky SR, Bollig-Fischer A. Abstract 1396: Role of epigenetic reader and alternative mRNA splicing variant MBD2 variant 2 in triple-negative breast cancer Cancer Research. 77: 1396-1396. DOI: 10.1158/1538-7445.Am2017-1396 |
0.436 |
|
| 2017 |
Holowatyj AN, Cote ML, Schwartz AG, Boerner J, Colacino J, Dyson G, Bandyopadhyay S, Purrington KS. 42PGenetic mediators of tumor-infiltrating lymphocytes associated with survival among African American women with triple-negative breast cancer Annals of Oncology. 28. DOI: 10.1093/Annonc/Mdx140.004 |
0.456 |
|
| 2016 |
Linklater ES, Tovar EA, Essenburg CJ, Turner L, Madaj Z, Winn ME, Melnik MK, Korkaya H, Maroun CR, Christensen JG, Steensma MR, Boerner JL, Graveel CR. Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers. Oncotarget. PMID 27655711 DOI: 10.18632/Oncotarget.12065 |
0.548 |
|
| 2016 |
Zoratti GL, Tanabe LM, Hyland TE, Duhaime MJ, Colombo É, Leduc R, Marsault E, Johnson MD, Lin CY, Boerner J, Lang JE, List K. Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer. Oncotarget. PMID 27528224 DOI: 10.18632/Oncotarget.11262 |
0.525 |
|
| 2016 |
Joiakim A, Mathieu PA, Shelp C, Boerner J, Reiners JJ. Epidermal Growth Factor Receptor Kinase Inhibitors Synergize with TCDD to Induce CYP1A1/1A2 in Human Breast Epithelial MCF10A Cells. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 44: 665-71. PMID 26953171 DOI: 10.1124/Dmd.115.066274 |
0.463 |
|
| 2016 |
Tovar EA, Linklater ES, Essenburg CJ, Madaj Z, Cherba DM, Winn ME, Korkaya H, Boerner JL, Graveel CR. Abstract B14: Targeting the intratumoral heterogeneity of receptor tyrosine kinases in breast cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B14 |
0.615 |
|
| 2015 |
Zoratti GL, Tanabe LM, Varela FA, Murray AS, Bergum C, Colombo É, Lang JE, Molinolo AA, Leduc R, Marsault E, Boerner J, List K. Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling. Nature Communications. 6: 6776. PMID 25873032 DOI: 10.1038/Ncomms7776 |
0.553 |
|
| 2015 |
Boerner JL, Nechiporchik N, Mueller KL, Polin L, Heilbrun L, Boerner SA, Zoratti GL, Stark K, LoRusso PM, Burger A. Protein expression of DNA damage repair proteins dictates response to topoisomerase and PARP inhibitors in triple-negative breast cancer. Plos One. 10: e0119614. PMID 25774912 DOI: 10.1371/Journal.Pone.0119614 |
0.404 |
|
| 2014 |
Madden JM, Mueller KL, Bollig-Fischer A, Stemmer P, Mattingly RR, Boerner JL. Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer. Breast Cancer Research and Treatment. 147: 283-93. PMID 25129346 DOI: 10.1007/S10549-014-3102-8 |
0.527 |
|
| 2014 |
Dhruv HD, Nelson AD, Armstrong B, Boerner JL, Sarkaria JN, Tran NL, Berens M. Abstract 1319: Vulnerability and resistance in glioblastoma to G2-specific drugs Cancer Research. 74: 1319-1319. DOI: 10.1158/1538-7445.Am2014-1319 |
0.373 |
|
| 2014 |
Madden J, Mueller K, Bollig-Fischer A, Stemmer P, Boerner J. EIF4B as a Novel Target in EGFR Expressing Triple Negative Breast Cancer Annals of Oncology. 25: i21. DOI: 10.1093/Annonc/Mdu069.3 |
0.538 |
|
| 2013 |
Xu J, Xu Z, Zhou JY, Zhuang Z, Wang E, Boerner J, Wu GS. Regulation of the Src-PP2A interaction in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. The Journal of Biological Chemistry. 288: 33263-71. PMID 24100030 DOI: 10.1074/Jbc.M113.508093 |
0.428 |
|
| 2013 |
Kim EMH, Mueller K, Gartner E, Boerner J. Dasatinib is synergistic with cetuximab and cisplatin in triple-negative breast cancer cells. Journal of Surgical Research. 185: 231-239. PMID 23899511 DOI: 10.1016/J.Jss.2013.06.041 |
0.588 |
|
| 2013 |
Zoratti GL, Bergum C, Boerner JL, List K. Abstract 5066: Matriptase mediated signaling in breast cancer. Cancer Research. 73: 5066-5066. DOI: 10.1158/1538-7445.Am2013-5066 |
0.557 |
|
| 2013 |
Madden J, Mueller K, Bollig-Fischer A, Stemmer P, Boerner J. Abstract 1026: Combating resistance to EGFR inhibitors: eIF4B as a novel target. Cancer Research. 73: 1026-1026. DOI: 10.1158/1538-7445.Am2013-1026 |
0.514 |
|
| 2012 |
Mueller KL, Powell K, Madden JM, Eblen ST, Boerner JL. EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK. Translational Oncology. 5: 327-34. PMID 23066441 DOI: 10.1593/Tlo.12163 |
0.527 |
|
| 2012 |
Hou J, Wu J, Dombkowski A, Zhang K, Holowatyj A, Boerner JL, Yang ZQ. Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer. American Journal of Translational Research. 4: 247-56. PMID 22937203 |
0.45 |
|
| 2012 |
Mueller KL, Madden JM, Zoratti GL, Kuperwasser C, List K, Boerner JL. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met. Breast Cancer Research : Bcr. 14: R104. PMID 22788954 DOI: 10.1186/Bcr3224 |
0.532 |
|
| 2012 |
Giordano CR, Mueller KL, Terlecky LJ, Krentz KA, Bollig-Fischer A, Terlecky SR, Boerner JL. A targeted enzyme approach to sensitization of tyrosine kinase inhibitor-resistant breast cancer cells. Experimental Cell Research. 318: 2014-21. PMID 22687878 DOI: 10.1016/J.Yexcr.2012.06.001 |
0.53 |
|
| 2012 |
Bergum C, Zoratti G, Boerner J, List K. Strong expression association between matriptase and its substrate prostasin in breast cancer. Journal of Cellular Physiology. 227: 1604-9. PMID 21678412 DOI: 10.1002/Jcp.22877 |
0.454 |
|
| 2012 |
Hou J, Wu J, Dombkowski A, Boerner JL, Ethier S, Yang Z. Abstract 2192: Genomic amplification and drug-resistance roles of the KDM5A histone demethylase gene in breast cancer Cancer Research. 72: 2192-2192. DOI: 10.1158/1538-7445.Am2012-2192 |
0.505 |
|
| 2012 |
Madden J, Mueller K, Bollig-Fischer A, Stemmer P, Boerner J. Abstract 1068: Inhibition of the phosphorylation of eIF4 molecules sensitizes EGFR expressing breast cancers to EGFR inhibitors Cancer Research. 72: 1068-1068. DOI: 10.1158/1538-7445.Am2012-1068 |
0.582 |
|
| 2011 |
Irwin ME, Bohin N, Boerner JL. Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells. Cancer Biology & Therapy. 12: 718-26. PMID 21775822 DOI: 10.4161/Cbt.12.8.16907 |
0.572 |
|
| 2011 |
Irwin ME, Mueller KL, Bohin N, Ge Y, Boerner JL. Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. Journal of Cellular Physiology. 226: 2316-28. PMID 21660955 DOI: 10.1002/Jcp.22570 |
0.455 |
|
| 2011 |
Mueller KL, Boerner JL. Abstract 2911: EGFR and c-Src crosstalk in breast cancer cell migration Cancer Research. 71: 2911-2911. DOI: 10.1158/1538-7445.Am2011-2911 |
0.582 |
|
| 2011 |
Gartner E, Kim E, Choi L, Boerner J. PD08-08: Preclinical Efficacy of the Combination of Met and Src Family Kinase Inhibitors in Triple-Negative Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-Pd08-08 |
0.486 |
|
| 2011 |
Kim E, Gartner E, Choi L, Boerner J. P3-16-16: Overcoming EGFR Resistance Using Dasatinib in Combination with Cetuximab and Cisplatin in Triple Negative Breast Cancer Cell Lines. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P3-16-16 |
0.574 |
|
| 2010 |
Mueller KL, Yang ZQ, Haddad R, Ethier SP, Boerner JL. EGFR/Met association regulates EGFR TKI resistance in breast cancer. Journal of Molecular Signaling. 5: 8. PMID 20624308 DOI: 10.1186/1750-2187-5-8 |
0.506 |
|
| 2010 |
Mueller KL, Haddad R, Yang Z, Ethier SP, Boerner JL. Abstract 278: Regulation of constitutive Met phosphorylation in breast cancer by EGFR Cancer Research. 70: 278-278. DOI: 10.1158/1538-7445.Am10-278 |
0.563 |
|
| 2010 |
Irwin ME, Mueller KL, Boerner JL. Abstract 269: Disruption of lipid rafts sensitizes EGFR expressing breast cancer cells to EGFR inhibitors Cancer Research. 70: 269-269. DOI: 10.1158/1538-7445.Am10-269 |
0.576 |
|
| 2009 |
Demory ML, Boerner JL, Davidson R, Faust W, Miyake T, Lee I, Hüttemann M, Douglas R, Haddad G, Parsons SJ. Epidermal growth factor receptor translocation to the mitochondria: regulation and effect. The Journal of Biological Chemistry. 284: 36592-604. PMID 19840943 DOI: 10.1074/Jbc.M109.000760 |
0.393 |
|
| 2009 |
Edwards H, Xie C, LaFiura KM, Dombkowski AA, Buck SA, Boerner JL, Taub JW, Matherly LH, Ge Y. RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia. Blood. 114: 2744-52. PMID 19638627 DOI: 10.1182/Blood-2008-09-179812 |
0.377 |
|
| 2009 |
Boerner JL. Role of Src family kinases in acquired resistance to EGFR therapies in cancer. Cancer Biology & Therapy. 8: 704-6. PMID 19417559 DOI: 10.4161/Cbt.8.8.8183 |
0.398 |
|
| 2009 |
Mueller K, Haddad R, Boerner J. Constitutive c-Met phosphorylation mediates growth in the absence of EGFR kinase activity in breast cancer cells dependent on EGFR expression for growth. Cancer Research. 69: 4059. DOI: 10.1158/0008-5472.Sabcs-4059 |
0.513 |
|
| 2008 |
Mueller KL, Hunter LA, Ethier SP, Boerner JL. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells. Cancer Research. 68: 3314-22. PMID 18451158 DOI: 10.1158/0008-5472.Can-08-0132 |
0.541 |
|
| 2007 |
Streicher KL, Willmarth NE, Garcia J, Boerner JL, Dewey TG, Ethier SP. Activation of a nuclear factor kappaB/interleukin-1 positive feedback loop by amphiregulin in human breast cancer cells. Molecular Cancer Research : McR. 5: 847-61. PMID 17670913 DOI: 10.1158/1541-7786.Mcr-06-0427 |
0.411 |
|
| 2005 |
Boerner JL, Biscardi JS, Silva CM, Parsons SJ. Transactivating agonists of the EGF receptor require Tyr 845 phosphorylation for induction of DNA synthesis. Molecular Carcinogenesis. 44: 262-73. PMID 16167350 DOI: 10.1002/Mc.20138 |
0.449 |
|
| 2005 |
Boerner JL, Gibson MA, Fox EM, Posner ED, Parsons SJ, Silva CM, Shupnik MA. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 19: 2660-70. PMID 15976008 DOI: 10.1210/Me.2004-0439 |
0.494 |
|
| 2004 |
Boerner JL, Demory ML, Silva C, Parsons SJ. Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Molecular and Cellular Biology. 24: 7059-71. PMID 15282306 DOI: 10.1128/Mcb.24.16.7059-7071.2004 |
0.366 |
|
| 2003 |
Kloth MT, Laughlin KK, Biscardi JS, Boerner JL, Parsons SJ, Silva CM. STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor. The Journal of Biological Chemistry. 278: 1671-9. PMID 12429742 DOI: 10.1074/jbc.M207289200 |
0.369 |
|
| Show low-probability matches. |